Report Highlights

CBD Confectionery in the United States: Market Overview

The U.S. market for CBD-infused confectionery is a hemp-derived category worth an estimated USD 1.12 billion in 2024. The Agriculture Improvement Act of 2018 removed hemp and its derivatives from the Controlled Substances Act, provided THC stays at or below 0.3 percent on a dry weight basis. Unlike Canada, where cannabinoid edibles sit under the Cannabis Act, U.S. products sell through conventional retail channels without a federal food additive approval.

The category is structurally fragmented. Gummies account for the largest share of units, and direct-to-consumer web sales operated by Charlotte's Web and cbdMD remain a major revenue channel. Retail distribution runs through vape shops, natural grocers, convenience stores, and licensed dispensaries, producing wide price dispersion between premium 25 mg gummies and low-cost bulk packs.

Growth Drivers in U.S. CBD Confectionery

Consumer demand for sleep, stress, and recovery products is the first driver. Millennial and Gen Z buyers favour discreet, dose-measured gummies over tinctures, and analyst estimates place gummies at roughly 40 percent of U.S. CBD product sales. This preference supports steady volume growth even as wholesale prices for raw CBD isolate have declined since 2019.

The second driver is state-level market formalisation. New York's Cannabinoid Hemp Program, administered by the Office of Cannabis Management, sets licensing and testing rules that allow licensed retailers to sell CBD edibles. Colorado's Industrial Hemp Program and Kentucky's hemp licensing regime provide the cultivation base that supports lower-cost confectionery input supply.

Market Restraints and Entry Barriers

The FDA has stated that CBD cannot be added to food or sold as a dietary supplement under current law, leaving brands dependent on wellness marketing that avoids disease claims. The Federal Trade Commission enforces advertising substantiation rules, and several states restrict CBD added to food and beverage products. Entrants must map each state's food and hemp rules before committing to distribution.

Distribution is a second barrier. Major online marketplaces such as Amazon prohibit ingestible CBD listings, forcing brands onto proprietary websites and limiting customer acquisition. Banking access remains constrained because financial institutions apply restrictive compliance review to hemp-derived product sellers, which raises the cost of payment processing and working capital.

Market Opportunities in the United States

The most immediate opportunity lies in states with defined licensing frameworks. New York's hemp program and Florida's hemp registration regime allow compliant brands to enter grocery and pharmacy-adjacent retail, an addressable channel that analysts estimate at over USD 300 million of the 2024 category value. Brands that secure state approvals early can capture shelf placement before competitors.

A second opportunity is premium sleep-focused confectionery. Dispensary-licensed chocolate and baked goods in California and Colorado command price premiums above mainstream gummies, and the segment represents an estimated USD 180 million pool. Entrants with verified third-party testing and transparent certificates of analysis can use that credibility to command higher margins.

Market at a Glance

Leading Market Participants

• Charlotte's Web
• cbdMD
• Lord Jones
• Green Roads
• Hemp Bombs
• Wana Brands
• Kiva Confections
• Papa & Barkley
• Medterra
• Exhale Wellness

Regulatory and Policy Environment

The Agriculture Improvement Act of 2018, Public Law 115-334, established the federal hemp framework. The USDA Agricultural Marketing Service administers the Domestic Hemp Production Program under 7 CFR Part 990, requiring state or tribal plans and producer licensing before cultivation. Federal appropriations legislation enacted in late 2025 redefines hemp to exclude intoxicating products, with implementation set for November 2026.

At the state level, the New York Office of Cannabis Management and the Colorado Department of Agriculture set licensing and testing requirements. The FDA retains authority over food additive and drug claims under the Federal Food, Drug, and Cosmetic Act, while the FTC polices health claims. Entrants should budget for state registration, batch testing, and label review, typically requiring six to nine months before first retail sale.

Long-Term Outlook for U.S. CBD Confectionery

By 2032, the U.S. CBD-infused confectionery market is forecast to reach USD 2.45 billion, growing at a 10.3% CAGR from the 2024 base. Growth will concentrate in states with formal licensing regimes, while markets dependent on unregulated sales will contract. Federal intoxicating-hemp restrictions will reshape product formulations toward non-intoxicating full-spectrum and isolate-based products.

Consolidation is the likely structural outcome. Brands with integrated hemp supply, verified testing, and multi-state retail access will gain share, while sub-scale entrants without compliance capacity will exit. Premium sleep and recovery positioning will outperform commodity gummies on margin, shaping competitive investment through the forecast period.